Evidence map›Paper›PMID 42700105›Full record

ArticleEpilepsia open2026

Electroclinical classification of idiopathic generalized epilepsy syndromes at initial evaluation: A prospective multicenter study.

Omar Nawfal, Heba Samara, Wassim Nasreddine, Fatima Jaafar, Mahasen Reda, Tarek Halabi, Ahmad Beydoun

Abstract read
In one paragraph

Article in Epilepsia open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Omar NawfalDepartment of Neurology, UT Southwestern Medical Center, Dallas, Texas, USA.ORCID https://orcid.org/0000-0002-7066-1811
Heba SamaraDepartment of Neurology, American University of Beirut Medical Center, Beirut, Lebanon.ORCID https://orcid.org/0009-0000-4255-478X
Wassim NasreddineDepartment of Neurology, American University of Beirut Medical Center, Beirut, Lebanon.ORCID https://orcid.org/0000-0001-6487-8259
Fatima JaafarDepartment of Neurology, American University of Beirut Medical Center, Beirut, Lebanon.ORCID https://orcid.org/0000-0002-5519-9278
Mahasen RedaDepartment of Neurology, American University of Beirut Medical Center, Beirut, Lebanon.ORCID https://orcid.org/0009-0007-9406-4599
Tarek HalabiDepartment of Neurology, American University of Beirut Medical Center, Beirut, Lebanon.ORCID https://orcid.org/0000-0002-1197-1393
Ahmad BeydounDepartment of Neurology, American University of Beirut Medical Center, Beirut, Lebanon.ORCID https://orcid.org/0000-0002-9047-1185

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determine the extent to which electroclinical information available at initial evaluation allows classification of idiopathic generalized epilepsy (IGE) syndromes, and to assess the contributions of seizure semiology and age at seizure onset to early syndromic diagnosis.

methodsWe prospectively analyzed a cohort of patients with new-onset seizures who underwent a structured clinical evaluation, including detailed history-taking, 3-h video-EEG, and epilepsy-protocol MRI. Seizure semiology was assessed at three levels: index seizure, initial seizure type, and seizure types identified at initial evaluation. Syndromic classification followed International League Against Epilepsy criteria. Final electroclinical diagnosis, established after longitudinal follow-up, served as reference. Within patients ultimately diagnosed with one of the four IGE syndromes, baseline data were used to determine whether the final syndrome could be assigned at initial evaluation.

resultsOf 2699 patients evaluated, 498 (18.4%) met criteria for genetic generalized epilepsy, of whom 401 (80.5%) were classified as having one of the IGE syndromes. Based on initial evaluation, the correct syndrome could be assigned in 366 patients (91.3%), whereas 7 (1.7%) would have been misclassified and 28 (7.0%) were not assignable. Non-assignability was confined to absence epilepsies, reflecting overlap between childhood (CAE) and juvenile absence epilepsy (JAE), whereas misclassification occurred only in juvenile myoclonic epilepsy (JME) presenting with isolated generalized tonic-clonic (GTC) seizures. Classification based on the index seizure alone showed limited accuracy (63.6%), whereas incorporation of seizure types identified through structured history improved classification to 95.0%. Myoclonic seizures were highly specific for JME, whereas absence and GTC seizures required integration with additional features. Age at seizure onset strongly differentiated CAE from JAE (AUC 0.935). SIGNIFICANCE: Electroclinical classification of IGE syndromes is frequently achievable at initial evaluation when based on seizure semiology and age at onset. When classification is not possible, limitations follow predictable electroclinical patterns, supporting a structured, history-driven diagnostic approach. PLAIN LANGUAGE SUMMARY: This study examined how accurately doctors can identify specific types of generalized epilepsy when patients are first evaluated. Among 401 patients with generalized epilepsy, the correct epilepsy syndrome could be identified in more than 90% at the first visit. Looking beyond the first seizure and asking about all seizure types together with age at seizure onset greatly improved diagnosis. While some overlap exists between specific types (like childhood versus juvenile absence epilepsy), a thorough clinical evaluation from the start provides reliable diagnostic direction for patients and supports early and accurate diagnosis.

Indexed as

classificationfirst seizuregenetic generalized epilepsyindex seizure

Identifiers

PMID42700105
PMCPMC13545738

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.